
The company obtained an approval from the Drugs Controller General of India to conduct Phase-1 trials followed by Phase-II trials to assess the safety, reactogenicity and immunogenicity of their vaccine.
from Top India News- News18.com https://ift.tt/36rJH8O
via
IFTTT
No comments:
Post a Comment